HorizonTech
HorizonTech Raises $350M Series E to Transform Biotech
Quick Facts
HorizonTech Raises $350M Series E in Latest Funding Round
HorizonTech has successfully closed a $350M Series E funding round, marking a significant milestone in the company's growth trajectory. The round was led by 500 Startups, with participation from Khosla Ventures.
Company Overview
Founded in 2023 and headquartered in Portland, OR, HorizonTech has established itself in the Biotech space. Leading AI-powered analytics platform transforming data into actionable business insights
With a current valuation of $5B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $350M Series E
- Valuation: $5B
- Lead Investor: 500 Startups
Future Outlook
As HorizonTech moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
PrimeNet Raises $300M Series C to Transform Biotech
PrimeNet has secured $300M Series C in funding to accelerate growth and innovation. Leading machine learning platform automating enterprise workflows with advanced AI models...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...